Entrar Registro gratuito

Last updated: 23 March 2020 at 5:09pm EST

David Schreiber Net Worth




The estimated Net Worth of David Schreiber is at least $800 mil dollars as of 3 June 2019. Mr. Schreiber owns over 10,000 units of Vermillion stock worth over $659,620 and over the last 9 years he sold VRML stock worth over $41,000. In addition, he makes $99,000 as Independent Director at Vermillion.

Mr. Schreiber VRML stock SEC Form 4 insiders trading

David has made over 2 trades of the Vermillion stock since 2019, according to the Form 4 filled with the SEC. Most recently he sold 10,000 units of VRML stock worth $11,000 on 3 June 2019.

The largest trade he's ever made was selling 30,000 units of Vermillion stock on 7 March 2019 worth over $30,000. On average, David trades about 4,444 units every 10 days since 2015. As of 3 June 2019 he still owns at least 164,905 units of Vermillion stock.

You can see the complete history of Mr. Schreiber stock trades at the bottom of the page.





David Schreiber biography

David R. Schreiber serves as Independent Director of the Company. David Schreiber became a director of Vermillion in December 2014. He serves as the Chair of our Audit Committee since June 2016 and previously served as a member of our Audit Committee from December 2014 to January 2016. He is also a member of our Nominating and Governance Committee. Mr. Schreiber has held a variety of executive positions in the diagnostic laboratory industry for the past 28 years. For over 15 years, Mr. Schreiber has consulted for private equity firms to assist with their due diligence efforts and served in various interim operating roles for targeted or existing portfolio companies. From 1986 to 1996, Mr. Schreiber was at Quest Diagnostics, initially in a variety of financial roles, his last position being Vice President and General Manager of Quest's Midwest Region, based in Chicago, Illinois. Following Quest, from 1996 to 2003, Mr. Schreiber was Senior Vice President and Chief Financial Officer of Dianon Systems, a publicly traded specialized pathology company, until Dianon was acquired by LabCorp. Mr. Schreiber was also a member of Dianon's board of directors. Following Dianon, Mr. Schreiber joined the board of directors of Specialty Labs, a publicly traded lab company focused on serving the esoteric needs of hospitals. Mr. Schreiber helped lead the turnaround of Specialty Labs which led to its successful sale to Ameripath/Welsh Carson. At the same time, Mr. Schreiber joined and previously served on the board of Nanogen, a publicly traded nanotechnology company and also began his consulting career. Mr. Schreiber received a B.S. in Finance and an M.B.A. from Northern Illinois University.

What is the salary of David Schreiber?

As the Independent Director of Vermillion, the total compensation of David Schreiber at Vermillion is $99,000. There are 5 executives at Vermillion getting paid more, with Valerie Palmieri having the highest compensation of $941,832.



How old is David Schreiber?

David Schreiber is 60, he's been the Independent Director of Vermillion since 2014. There are 3 older and 3 younger executives at Vermillion. The oldest executive at Vermillion, Inc. is James Burns, 73, who is the Independent Director.

What's David Schreiber's mailing address?

David's mailing address filed with the SEC is C/O VERMILLION, INC., 12117 BEE CAVES RD, BLDG 3-100, AUSTIN, TX, 78738.

Insiders trading at Vermillion

Over the last 17 years, insiders at Vermillion have traded over $1,008,376 worth of Vermillion stock and bought 29,557,130 units worth $34,088,488 . The most active insiders traders include Jack W Schuler, Henri George Schuler, eLarry Noracle Partners Lp F.... On average, Vermillion executives and independent directors trade stock every 59 days with the average trade being worth of $1,572,028. The most recent stock trade was executed by Robert Harry Beechey on 15 November 2019, trading 5,000 units of VRML stock currently worth $3,550.



What does Vermillion do?

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. Its bio-analytical solutions helps physicians diagnose, treat, and improve gynecologic health outcomes for women. The company was founded on December 9, 1993 and is headquartered in Austin, TX.



What does Vermillion's logo look like?

Vermillion, Inc. logo

Complete history of Mr. Schreiber stock trades at Vermillion

Data
#
Companhia
 Acionista maioritário
Trans.
Transação
 Ações Preço por ação Preço total Ações após Fonte
3 Jun 2019 VRML Vermillion, Inc. David Schreiber
Diretor
 Venda 10,000 $1.10 $11,000
3 Jun 2019
164,905 ↗
7 Mar 2019 VRML Vermillion, Inc. David Schreiber
Diretor
 Venda 30,000 $1.00 $30,000
7 Mar 2019
137,405 ↗


Vermillion executives and stock owners

Vermillion executives and other stock owners filed with the SEC include: